Yu-Ting Cheng

Title: Innovations in Cancer Treatment by Yu-Ting Cheng

Introduction

Yu-Ting Cheng is an accomplished inventor based in Taichung, Taiwan. He has made significant contributions to the field of cancer treatment through his innovative research and development of new therapeutic agents.

Latest Patents

Yu-Ting Cheng holds a patent for "Sesquiterpene derivatives and their use in inflammation or cancer treatment." This patent discloses a new class of sesquiterpene derivatives that are useful for treating cancerous and inflammatory diseases. The deoxyelephantopin derivatives described in the patent are effective in suppressing proliferation, migration, mobility, invasion, growth, and/or metastasis of cancer cells in patients. Additionally, these derivatives can enhance the anti-proliferative effect of other anti-cancer drugs or sensitize the effects of glutathione synthesis blockers on triple-negative breast cancer cell activity. The patent also covers methods for preparing these deoxyelephantopin derivatives.

Career Highlights

Yu-Ting Cheng is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work focuses on developing innovative solutions for complex medical challenges, particularly in oncology and inflammation.

Collaborations

Yu-Ting Cheng has collaborated with notable colleagues, including Lie-Fen Shyur and Kuo-Hsiung Lee, to advance his research and enhance the impact of his inventions.

Conclusion

Yu-Ting Cheng's innovative work in developing sesquiterpene derivatives represents a significant advancement in cancer treatment and inflammation management. His contributions continue to pave the way for new therapeutic options in the medical field.